Agenda
- Understanding the Current Role of Therapeutic Strategies in the Personalized Care of Patients With NSCLC
- Optimal Management of Disease-Related and Treatment-Related Adverse Events
- Explaining Treatment Strategies and Procedures to Patients
- Closing Remarks and Question and Answer Session
Events
Date / Time
Event Details
10/12/2017
6:30 PM
Scottsdale, AZ
Maggiano's Little Italy Scottsdale
Details
Faculty
![]()
Program Director
Diane Cope, PhD, ARNP-BC, AOCNP
Oncology Nurse Practitioner
Chair, Clinical Directions Team
Florida Cancer Specialists and Research Institute
Fort Myers, Florida
Program Director
Anne Zobec, APN
Oncology Nurse Practitioner
Rocky Mountain Cancer Center
Colorado Springs, Colorado
Faculty
Gail Kwarciany, MSN, RN-BC, OCN, AOCNS
Oncology Clinical Nurse Specialist
The University of Texas Medical Branch
Galveston, Texas
![]()
Faculty
Jody Pelusi, PhD, FNP, AOCNP
Oncology Nurse Practitioner/Sub-Investigator and Nurse Researcher
Honor Health Research Institute
Oncology Nurse Practitioner
Breast Cancer Services
Yavapai Regional Medical Center
Oncology Nurse Practitioner
Summit Health Care
Phoenix, Arizona
CME
Program Overview
These hour-long, interactive, case-based workshops will explore the role of the nurse in caring for patients with non-small-cell lung cancer. Expert oncology nurses will review and discuss the latest treatments for patients with newly diagnosed or relapsed/refractory NSCLC, strategies for dosing and adverse event management, and approaches to educating patients as partners in their own care.
Goal Statement
The goal of this activity is to improve participants’ competence in personalizing treatment of non-small-cell lung cancer to individual patients.
Target Audience
This program is intended for registered nurses and other healthcare providers who care for patients with non-small-cell lung cancer.
Learning Objectives
- Explain the rationale for and the importance of biopsy procedures to patients with non-small-cell lung cancer
- Communicate effectively with patients with advanced or metastatic non-small-cell lung cancer so that they will understand their individualized treatment plan
- Gain insight on individualized choice of chemotherapy based on histology as well as patient age/fitness, comorbidities, and preference
- Manage treatment-related and disease-related adverse events in patients with non-small-cell lung cancer
Accreditation
Nursing Continuing Education
Credit Designation
This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine.
Accreditation Statement
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 1.0 contact hour.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3 weeks.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.